ACCESSION: MSBNK-SMB_Measured-HSA001P0443000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'4_posi_2580': {'bp': 575775.0, 'sum': 767284.0}, '6_posi_2596': {'bp': 450792.0, 'sum': 606952.0}, '11_posi_2597': {'bp': 436146.0, 'sum': 559468.0}, '7_posi_2577': {'bp': 418660.0, 'sum': 535376.0}, '15_posi_2644': {'bp': 414886.0, 'sum': 540916.0}, '2_posi_2539': {'bp': 395024.0, 'sum': 480695.0}, '8_posi_2616': {'bp': 362534.0, 'sum': 488143.0}, '12_posi_2622': {'bp': 337738.0, 'sum': 452686.0}, '18_posi_2685': {'bp': 304345.0, 'sum': 417622.0}, '5_posi_2593': {'bp': 295307.0, 'sum': 413026.0}, '19_posi_2749': {'bp': 285242.0, 'sum': 430653.0}, '14_posi_2621': {'bp': 268330.0, 'sum': 412204.0}, '17_posi_2665': {'bp': 267462.0, 'sum': 416592.0}, '13_posi_2642': {'bp': 162529.0, 'sum': 260521.0}}
COMMENT: RETENTION_TIME_STDEV 0.105
COMMENT: PRECURSOR_M/Z_RAW 443.242713
COMMENT: PRECURSOR_M/Z_STDEV 0.000293
COMMENT: PRECURSOR_IN_MS1 mz 443.243641; int 5.148; delta(ppm) 1.479948
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.362; C18H40N2O6P2; [M+H]+; delta(ppm) 0.361798
COMMENT: PROPOSED_MF MS-FINDER 2.499; C19H34N6O4S; [M+H]+; delta(ppm) 0.207451
COMMENT: PROPOSED_MF MS-FINDER 2.379; C12H42N8OS4; [M+H]+; delta(ppm) -0.283034
COMMENT: PROPOSED_MF MS-FINDER 2.054; C11H30N12O7; [M+H]+; delta(ppm) 0.620806
COMMENT: PROPOSED_MF MS-FINDER 1.845; C18H40N2O6P2; [M+H]+; delta(ppm) 0.359950
COMMENT: PROPOSED_MF MS-FINDER 1.504; C27H38OS2; [M+H]+; delta(ppm) -0.205905
COMMENT: PROPOSED_MF SIRIUS5_Sirius 11.534; C22H30N6O4; [M+H]+; delta(ppm) 7.813098
COMMENT: PROPOSED_MF SIRIUS5_Sirius 6.539; C27H30N4O2; [M+H]+; delta(ppm) -1.262651
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.325; C26H34O6; [M+H]+; delta(ppm) 1.754685
COMMENT: PROPOSED_MF SIRIUS5_Sirius 4.231; C24H34N4O2S; [M+H]+; delta(ppm) -8.868160
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.415; C26H35ClN2O2; [M+H]+; delta(ppm) -51369.922247
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.992; C22H30N6O4; [M+H]+; delta(ppm) 7.813098
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.007; C27H30N4O2; [M+H]+; delta(ppm) -1.262651
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.002; C24H34N4O2S; [M+H]+; delta(ppm) -8.868160
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.924; C22H30N6O4; [M+H]+; delta(ppm) 7.813098
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.890; C22H28F2N8; [M+H]+; delta(ppm) -9.435771
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.928; C27H30N4O2; [M+H]+; delta(ppm) -1.262651
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.903; C22H31ClN8; [M+H]+; delta(ppm) -51364.470308
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.866; C19H34N6O4S; [M+H]+; delta(ppm) 0.207451
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.733; C20H27FN10O; [M+H]+; delta(ppm) 2.217771
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.715; C26H34O6; [M+H]+; delta(ppm) 1.754685
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.547; C17H28F2N10O2; [M+H]+; delta(ppm) -0.360170
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.471; C20H30N10S; [M+H]+; delta(ppm) -2.809876
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.049; C16H32F2N6O6; [M+H]+; delta(ppm) 2.657171
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.458; C22H30N6O4; [M+H]+; delta(ppm) 7.813098
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.346; C22H28F2N8; [M+H]+; delta(ppm) -9.435771
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.042; C22H31ClN8; [M+H]+; delta(ppm) -51364.470308
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.041; C19H34N6O4S; [M+H]+; delta(ppm) 0.207451
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.033; C20H27FN10O; [M+H]+; delta(ppm) 2.217771
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.030; C17H28F2N10O2; [M+H]+; delta(ppm) -0.360170
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.024; C20H30N10S; [M+H]+; delta(ppm) -2.809876
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.021; C16H32F2N6O6; [M+H]+; delta(ppm) 2.657171
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.003; C27H30N4O2; [M+H]+; delta(ppm) -1.262651
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C26H34O6; [M+H]+; delta(ppm) 1.754685
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; XJXBCJLZWKPOFG-LDBMYMGHNA-N; [M+H]+; CC(=O)N1CC[C@@]23[C@@H]1N1CC[C@@]22[C@H](NC4=CC=CC([C@@H]1[C@@H]1OC1(C)C)=C24)NC1=C3C=CC=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; OOAMKTKUUHRRBR-UHFFFAOYSA-N; [M+H]+; O=C(NCCC1=NC2=CC=CC=C2N1CCOC1=CC2=C(C=CC=N2)C=C1)C1CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; IKEYHUMJJABOOV-UHFFFAOYSA-N; [M+H]+; O=C(N1CCN(C(=O)CCCC2=CNC=3C=CC=CC32)CC1)CCC4=CNC=5C=CC=CC54
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; IXCZXEVOTBBOIR-UHFFFAOYSA-N; [M+H]+; O=C(NC=1C=CC=CC1)N2CC3C4=CC=C(C(=O)N4CC(C2)C3)C=5C=CC=CC5CN(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; MUHQNMKDPXQRIM-UHFFFAOYSA-N; [M+H]+; O=C1N2CCC=3C=4C=CC=CC4NC3C2(C(=O)N(C1)C5CCN(CC=6C=CC=CC6)CC5)C
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -319.176; DMFNYIYEQODXGX; [M+H]+; (2R)-N-[(3S)-2-oxopiperidin-3-yl]-4-(piperidine-4-carbonyl)-1-(pyridine-3-carbonyl)piperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -319.443; SFEHQZLGONFLAM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -373.091; RJKINBXLOBKLFI; [M+H]+; (2R)-4-(cyclohexanecarbonyl)-N-[(3S)-2-oxopiperidin-3-yl]-1-(pyrimidine-5-carbonyl)piperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -373.358; SJLRVQWFVKNYJP; [M+H]+; (2R)-1-(cyclohexanecarbonyl)-N-[(3S)-2-oxopiperidin-3-yl]-4-(pyrimidine-5-carbonyl)piperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -385.209; PLLYBDSMUUXXCM; [M+H]+; (2S)-4-(cyclohexanecarbonyl)-N-[(3S)-2-oxopiperidin-3-yl]-1-(pyrazine-2-carbonyl)piperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -385.475; YWOIZORAAPDYLI; [M+H]+; (2R)-1-(cyclohexanecarbonyl)-N-[(3S)-2-oxopiperidin-3-yl]-4-(pyrazine-2-carbonyl)piperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -388.953; AAPHFBIWUCKJCF; [M+H]+; Theophylline, 7-(2-hydroxy-3-(4-(p-methoxybenzyl)-1-piperazinyl)propyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -426.396; VZBHPTCAQDOYJZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -427.727; HSMDROHGQPNNQH; [M+H]+; [1-[(3S,3aR,6S,6aR)-3-(morpholine-4-carbonylamino)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]triazol-4-yl]methyl-benzyl-methylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -451.902; AGUUKKXWABRVBZ; [M+H]+; 8-[[4-(furan-2-carbonyl)piperazin-1-yl]methyl]-1,3-dimethyl-7-(3-methylbutyl)purine-2,6-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -482.399; GSKJIPYCYLQILY; [M+H]+; [(3S,3aR,6R,6aS)-3-[5-[4-(dimethylamino)phenyl]tetrazol-1-yl]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] N-cyclohexylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.091; DMFNYIYEQODXGX; [M+H]+; (2R)-N-[(3S)-2-oxopiperidin-3-yl]-4-(piperidine-4-carbonyl)-1-(pyridine-3-carbonyl)piperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -410.483; QOFSUEBVUJOFNC; [M+H]+; (2S,4S)-4-(4-acetamidopyrazol-1-yl)-N-benzyl-2-[[2-(dimethylamino)-2-oxoethoxy]methyl]pyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -434.740; BKDPZRZMIGQPTA; [M+H]+; (2S,4S)-4-(4-acetamidopyrazol-1-yl)-2-[[2-(dimethylamino)-2-oxoethoxy]methyl]-N-(3-methylphenyl)pyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -445.120; SFEHQZLGONFLAM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -446.612; DMFNYIYEQODXGX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -462.876; YWOIZORAAPDYLI; [M+H]+; 1-cyclohexanecarbonyl-N-(2-oxopiperidin-3-yl)-4-(pyrazine-2-carbonyl)piperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -464.368; PLLYBDSMUUXXCM; [M+H]+; 4-cyclohexanecarbonyl-N-(2-oxopiperidin-3-yl)-1-(pyrazine-2-carbonyl)piperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -480.744; HSMDROHGQPNNQH; [M+H]+; N-[6-(4-{[benzyl(methyl)amino]methyl}-1H-1,2,3-triazol-1-yl)-hexahydrofuro[3,2-b]furan-3-yl]morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -486.946; SJLRVQWFVKNYJP; [M+H]+; 1-cyclohexanecarbonyl-N-(2-oxopiperidin-3-yl)-4-(pyrimidine-5-carbonyl)piperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -488.437; RJKINBXLOBKLFI; [M+H]+; 4-cyclohexanecarbonyl-N-(2-oxopiperidin-3-yl)-1-(pyrimidine-5-carbonyl)piperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -489.022; AGUUKKXWABRVBZ; [M+H]+; 8-{[4-(furan-2-ylcarbonyl)piperazin-1-yl]methyl}-1,3-dimethyl-7-(3-methylbutyl)-3,7-dihydro-1H-purine-2,6-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.170; QOFSUEBVUJOFNC; [M+H]+; (2S,4S)-4-(4-acetamidopyrazol-1-yl)-N-benzyl-2-[[2-(dimethylamino)-2-oxoethoxy]methyl]pyrrolidine-1-carboxamide
COMMENT: CONFIDENCE Level 5: Exact mass of interest 443.243593; Observed in MS1; Charge state Unknown;
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 5.258
MS$FOCUSED_ION: PRECURSOR_M/Z 443.243593
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-004i-0900000000-de1561865bc8b188b5ab
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  111.0917323 67.5041 ? 111.091948 1.2152 11.66 1.0000 14
  128.1182696 999.0000 ? 128.118267 0.2966 0.00 0.9033 14
  255.2294947 75.4587 ? 255.229327 2.9503 18.01 0.6703 14
PK$NUM_PEAK: 3
PK$PEAK: m/z int. rel.int.
  111.091732 67.50 67
  128.118270 999.00 999
  255.229495 75.46 75
//
